Axogen, Inc. Files 8-K on Financials and Reg FD
Ticker: AXGN · Form: 8-K · Filed: Feb 25, 2025 · CIK: 805928
| Field | Detail |
|---|---|
| Company | Axogen, Inc. (AXGN) |
| Form Type | 8-K |
| Filed Date | Feb 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, regulation-fd
Related Tickers: AXGN
TL;DR
AXGN filed an 8-K, check for financial updates and Reg FD info.
AI Summary
Axogen, Inc. filed an 8-K on February 25, 2025, reporting on its results of operations and financial condition, as well as a Regulation FD disclosure. The filing does not contain specific financial figures or details about the nature of the disclosure.
Why It Matters
This filing indicates Axogen is providing updates on its financial performance and potentially material information to the public, which is crucial for investors to stay informed.
Risk Assessment
Risk Level: low — This is a routine filing reporting on financial condition and regulatory disclosures, not indicating any immediate adverse events.
Key Players & Entities
- Axogen, Inc. (company) — Registrant
- 0000805928-25-000010 (filing_id) — Accession Number
- February 25, 2025 (date) — Date of Report
- Minnesota (jurisdiction) — State of Incorporation
- Alachua, Florida (location) — Principal Executive Offices
FAQ
What specific financial results are being reported by Axogen, Inc. in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' but does not provide specific figures within the provided text.
What is the nature of the Regulation FD disclosure mentioned in the filing?
The filing states 'Regulation FD Disclosure' as an item, but the specific content of the disclosure is not detailed in the provided text.
When was this 8-K report filed with the SEC?
The report was filed as of February 25, 2025.
What is Axogen, Inc.'s primary business classification according to the filing?
Axogen, Inc. is classified under 'ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]'.
What is the principal executive office address for Axogen, Inc.?
The principal executive offices are located at 13631 Progress Boulevard, Suite 400, Alachua, Florida 32615.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 25, 2025 regarding Axogen, Inc. (AXGN).